XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options (Tables)
12 Months Ended
Dec. 31, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Schedule of stock options
         
  Options (Shares)  

Weighted Average Exercise Price

  Aggregate Intrinsic Value
Outstanding at December 31, 2020 $ $
Granted    
Exercised    
Forfeited    
Outstanding at December 31, 2021 $ $
Granted 2,650,000   0.28  
Exercised    
Forfeited    
Outstanding at December 31, 2022 2,650,000 $ 0.28 $
Exercisable at December 31, 2022 $ $
Schedule of outstanding and exercisable stock options
                    
Exercise Price  Stock Options Outstanding  Exercisable Stock Options  Remaining Contractual Life  Aggregate Intrinsic Value
$0.26    650,000    —     1.3 years  $—   
$0.28    2,000,000    —     6.0 years  $—   
 $  0.260.28    2,650,000    —     4.81 years  $—   
Executive Officer [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Schedule of granted stock options
                      
Stock Options  Exercise Price  Vesting Period  Services  Classification
 50,000   $0.26    5 years    Board    Non-statutory 
 50,000   $0.26    5 years    Board    Incentive 
 500,000   $0.26    2 years    Employment    Incentive 
 50,000   $0.26    5 years    Board    Non-statutory 
Consultants [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Schedule of granted stock options
                      
Stock Options  Exercise Price  Vesting Period  Services  Classification
 1,000,000   $0.28    3 years    Consultant    Non-statutory 
 1,000,000   $0.28    3 years    Consultant    Non-statutory